Revapharma Private Limited - pharma in Delhi, India. MCA registration details.
CIN U24299DL2019PTC347678 Incorporated 26 March 2019 ROC Delhi HQ Delhi, India
Converted to LLP Private Limited Company pharma
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Active GSTINs
1
GST registered
Last financials
Mar 2019
Balance sheet date
Last AGM
31 Oct 2019
Annual general meeting
Company status
Converted to LLP
MCA master data
Registrar
Delhi
ROC office

About Revapharma Private Limited

Data last updated:

Revapharma Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2019.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PTC347678. Its GSTIN is 07AAJCR4986N1ZG (Delhi).

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Its last annual general meeting (AGM) was held on 31 October 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Shop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096.

The last known website on record is revapharma.in.

Company details

CIN U24299DL2019PTC347678
Registration Number 347678
Incorporation Date 26 March 2019
ROC Delhi
Listing Status Unlisted
Company Status Converted to LLP

Contact details

Revapharma Private Limited's registered office is in Delhi, Delhi. Its website is revapharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Shop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Revapharma Private Limited, buy the company report.

Comprehensive company report
Revapharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Revapharma Private Limited

FY 2019 filings available

Financial Statement Summary

MetricsFY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Revapharma Private Limited, buy the company report.

Board of directors of Revapharma Private Limited

Revapharma has 3 former directors on record and no current directors listed.

Auditor

Revapharma Private Limited is audited by A M A A & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
A M A A & ASSOCIATESFY 2019013066C

Shareholding

The shareholding of Revapharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Revapharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Revapharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Revapharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAJCR4986N1ZGDelhiActive19 Jul 2019

To see the full GST registrations and return filing status of Revapharma Private Limited, buy the company report.

Recent activity

Revapharma Private Limited has 3 board changes on record since 2019: 0 appointments and 3 cessations. The latest: Nizar Balan ceased to be Director on 16 Feb 2020.

Ceased
Nizar Balan ceased to be Director.
Ceased
Vimal Raina ceased to be Additional Director.
AGM
Revapharma Private Limited last Annual general meeting of members was held on 31 Oct 2019 as per latest MCA records.
Ceased
Gurpreet Sandhu Singh ceased to be Director.
Filing
Revapharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
Incorporation
26 Mar 2019
Revapharma Private Limited was registered on 26 Mar 2019 with Roc Delhi & aged 7 years 7 months as per MCA records.

Frequently asked questions

Revapharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Revapharma was a private limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2019 and is registered under CIN U24299DL2019PTC347678. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Revapharma is U24299DL2019PTC347678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Revapharma was incorporated on 26 March 2019. It is registered with the Registrar of Companies, Delhi.

Revapharma can be reached through the website revapharma.in. Its registered office is in Delhi, India.

The registered office of Revapharma is at Shop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096.

The latest financial statements of Revapharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 31 October 2019. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Revapharma is 07AAJCR4986N1ZG, registered in Delhi.

Revapharma operated in the pharma industry, in the drug formulation and development segment.

Nizar Balan ceased to be Director on 16 Feb 2020. Vimal Raina ceased to be Additional Director on 16 Feb 2020. Gurpreet Sandhu Singh ceased to be Director on 12 Sep 2019.